{
  "abstract": "Objective\n\nTo evaluate long-term anthropometric, metabolic, reproductive, and bone mineral density (BMD) outcomes in girls with central precocious puberty (CPP) treated with Gonadotropin-Releasing Hormone analogues (GnRHa).Methods\n\nIn this retrospective cohort with cross-sectional follow-up assessment, 82 of 265 eligible females (30.9%) with central precocious puberty or central hypothalamic-pituitary-gonadal axis activation who had received GnRHa participated in long-term evaluation. Anthropometric outcomes, insulin sensitivity indices (HOMA-IR and QUICKI), hormonal profile, BMD, and reproductive outcomes including polycystic ovary syndrome (PCOS) were assessed. Analyses used available cases for each outcome; missing values were not imputed.Results\n\nThe mean age at final evaluation was 17.61 ± 4.3 years, and mean GnRHa treatment duration was 3.14 ± 1.9 years. Mean height at final follow-up was 159.85 ± 6.5 cm; the mean difference from baseline predicted adult height was 1.98 cm (95% CI, -0.37 to 4.34; P = 0.097). The distribution of BMI categories did not change significantly from baseline to final follow-up. Mean HOMA-IR and QUICKI were 3.76 ± 1.82 and 0.319 ± 0.025, respectively; among adults, 14/28 (50.0%) met each prespecified adult-derived threshold for reduced insulin sensitivity. PCOS was identified in 15/67 participants (22.4%). Mean lumbar and femoral BMD Z-scores were -0.25 ± 1.23 and -0.55 ± 1.03, respectively.Conclusions\n\nAmong participants who completed long-term follow-up, attained height was comparable at the group level with predicted adult and mid-parental height, and mean BMD Z-scores were within age- and sex-referenced ranges. PCOS and PCOS-related features were observed, while insulin sensitivity indices were associated with adiposity. Because only 30.9% of eligible patients participated and there was no untreated comparison group, these findings describe the evaluated cohort and should not be interpreted as causal effects of GnRHa treatment.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Endocrinology, The National Center (Institute) for Diabetes, Endocrinology, and Genetics, The University of Jordan, Amman, Jordan.",
    "Department of Public Health, Jordan University of Science and Technology (JUST), Irbid, Jordan.",
    "Faculty of Medicine, The University of Jordan, Amman, Jordan."
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 11,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Nahla Khawaja"
    },
    {
      "affs": [
        0
      ],
      "name": "Khalid Karaki"
    },
    {
      "affs": [
        1
      ],
      "name": "Mohammad K Ruba'i"
    },
    {
      "affs": [
        1
      ],
      "name": "Yousef Khader"
    },
    {
      "affs": [
        0
      ],
      "name": "Arwa Kinani"
    },
    {
      "affs": [
        0
      ],
      "name": "Oraib Farahid"
    },
    {
      "affs": [
        0
      ],
      "name": "Mohammed El-Khateeb"
    },
    {
      "affs": [
        2
      ],
      "name": "Omar Ali"
    },
    {
      "affs": [
        2
      ],
      "name": "Abdulrahman Abujbara"
    },
    {
      "affs": [
        2
      ],
      "name": "Laith Hyasat"
    },
    {
      "affs": [
        0
      ],
      "name": "Kamel Ajlouni"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/2a7gbn30yxjgf.bib",
  "cited_by": 0,
  "doi": "10.3389/fendo.2026.1911743",
  "fulltext_url": "https://europepmc.org/articles/PMC13677348",
  "id": "2a7gbn30yxjgf",
  "issns": [
    "1664-2392"
  ],
  "landing_url": "https://europepmc.org/article/MED/42898185",
  "language": "eng",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2743|Hypothalamic control of reproductive hormones"
    ]
  ],
  "openalex": "W7219822669",
  "pdf_url": "https://europepmc.org/articles/PMC13677348?pdf=render",
  "pmcid": "PMC13677348",
  "pmid": "42898185",
  "published": "2026-10-05",
  "publisher": "Frontiers Media SA",
  "ris": "https://research.draconitic.com/paper/2a7gbn30yxjgf.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:19:37Z",
      "native_id": "MED:42898185",
      "source": "europepmc",
      "url": "https://europepmc.org/article/MED/42898185"
    },
    {
      "first_seen": "2026-10-30T12:20:20Z",
      "native_id": "10.3389/fendo.2026.1911743",
      "source": "crossref",
      "url": "https://www.frontiersin.org/articles/10.3389/fendo.2026.1911743/full"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2743|Hypothalamic control of reproductive hormones",
      "subfield": "reproductive-child"
    }
  ],
  "title": "Long-term clinical outcomes in females with precocious puberty treated with gonadotropin-releasing hormone analogues.",
  "title_text": "Long-term clinical outcomes in females with precocious puberty treated with gonadotropin-releasing hormone analogues.",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:20:20Z",
  "url": "https://research.draconitic.com/paper/2a7gbn30yxjgf",
  "venue": "Frontiers in endocrinology",
  "versions": []
}